
Phase 1 driving simulation finds bedtime GlyphAllo for major depressive disorder shows no next-morning driving impairment, while advancing allopregnanolone-based oral treatment development.
Teen depression rises with screen time, potential new target for novel antidepressants, and more key findings here.
